nadproject
Nanoparticles for Therapy and Diagnosis of Alzheimer Disease
Press release
Third Annual Meeting Budapest - 1/3 June
Second Annual meeting in Milan (Italy) 20 - 21 Sept 2010
First Annual Meeting
The research is financed by the European Union's 7th Framework Program.
Grant agreement no: CP-IP 212043-2 NAD
Project start date: Sept. 1st, 2008
Home
Partners
Reserved Menu
Public Menu
Home
About NAD
Partners
Unimib Milano
UPS Paris
IC SAS Slovakia
KI Stockholm
AMC Amsterdam
BIO Hungary
PET Centre (TPC) Turku
Nanovector Torino
UPAT, Patras
Bio Imaging Lab, Antwerp
Universidad Bilbao
ULANC United Kingdom
Mario Negri, Milano
STAB VIDA, Portugal
Pierre et Marie Curies, Paris
GUERBET France
Bial Farmaceutica, Bilbao
UCPH Copenhagen
CIBERNED ISCIII Madrid
Events & News
NAD Publications
Jobs & Opportunities
Links
Find
Credits
Login
Remember Me
Forgot your password?
Main involved Partners:
University of Milano-Bicocca [UNIMIB], Milano, Italy
University of Paris-Sud XI [UPS], Paris, France
Institute of Chemistry Slovak Academy of Sciences [IC SAS], Bratislava, Slovakia
Karolinska Institutet [KI], Stockholm, Sweden
Academic Medical Center at the University of Amsterdam [AMC], Amsterdam, The Netherlands
BioTalentum Ltd. [BIO], Gödöllő, Hungary
University of Turku / Turku PET Centre [UTURKU], Turku, Finland
Nanovector srl., [NAV], Torino, Italy
University of Patras [UPAT], Patras, Greece
University of Antwerp, Bio-Imaging Lab, [UA], Antwerp, Belgium
Universidad del País Vasco, [UPV], Bilbao, Spain
Lancaster University [ULANC], Lancaster, United Kingdom
Mario Negri Institute for Pharmacological Research [IRF], Milano, Italy
Stab Vida, Lda. [STAB], Oeiras, Portugal
Université Pierre et Marie Curie [UPMC], Paris, France
Guerbet SA., [GUER], Villepinte, France
Bial Industrial Farmacéutica S.A., [BIAL], Bilbao, Spain
University of Copenhagen, [UCPH], Copenhagen, Denmark
Instituto de Salud CIII- CIBERNED- ISCIII, [CIBERNED], Madrid, Spain
Partners